GlassScriptPhysician profile
Stephen A Ditta
NPI 1487645552
$2,671.15
in general payments reported to CMS, 2019-2025
16 companies · $697 in 2025
The $697 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $143 · 2020: $52.14 · 2021: $61.72 · 2022: $221 · 2023: $599 · 2024: $898 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,115 · Entertainment: $78.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,115.06 |
| Entertainment | $78.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $545.35 | 2019-2025 | Precision7, Precision 1, Clareon |
| Sun Pharmaceutical Industries INC. | $412.25 | 2023-2025 | Cequa |
| Johnson & Johnson Vision Care, INC. | $244.47 | 2023-2024 | Acuvue |
| Dompe US, INC. | $233.60 | 2024 | Oxervate |
| Glaukos Corporation | $207.48 | 2024-2025 | Ce-Marked Kxla System, Photrexa Viscous and Photrexa |
| Oyster Point Pharma, INC. | $130.18 | 2023 | Tyrvaya |
| Ocular Therapeutix, INC. | $125.00 | 2024 | Dextenza |
| Abbvie INC. | $123.28 | 2022 | |
| Alexion Pharmaceuticals, INC. | $121.86 | 2025 | Ultomiris |
| Lkc Technologies, INC. | $119.21 | 2023 | |
| Optovue, INC. | $101.41 | 2019 | |
| Tarsus Pharmaceuticals, INC. | $94.25 | 2024 | Xdemvy |
| Bausch & Lomb Americas INC. | $83.33 | 2022 | |
| Optos, INC. | $78.28 | 2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Coopervision INC. | $30.32 | 2019-2024 | Synergeyes Contact Lens |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Ditta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.